Lapatinib and Capecitabine for Second Line Treatment of Pancreas Cancer
Clinical trial NCT00881621 · TERMINATED
Trial details
- NCT number
- NCT00881621
- Sponsor
- Georgetown University
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2009-08-01
- Primary completion
- 2012-12-01
- Enrollment
- 17
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.